Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study

BMC Nephrol. 2017 Oct 6;18(1):308. doi: 10.1186/s12882-017-0723-2.

Sandra Wagner^{1

2}, Marie Metzger¹, Martin Flamant³, Pascal Houillier^{4

5}, Jean-Philippe Haymann⁶, François Vrtovsnik³, Eric Thervet^{5

7}, Jean-Jacques Boffa⁶, Ziad A Massy^{1

2

8}, Bénédicte Stengel^{9

10}, Patrick Rossignol^{2

11}; NephroTest Study group

¹ CESP, Inserm U1018, Univ Paris-Saclay, Univ Paris-Sud, UVSQ, Villejuif, France.
² FCRIN INI-CRCT, Paris, France.
³ Bichat Hospital, Paris, France.
⁴ INSERM U1138, Paris, France.
⁵ HEGP, Paris, France.
⁶ Tenon Hospital, Paris, France.
⁷ INSERM, UMRS970, Boulogne-Billancourt, France.
⁸ Ambroise Paré Hospital, Boulogne-Billancourt, France.
⁹ CESP, Inserm U1018, Univ Paris-Saclay, Univ Paris-Sud, UVSQ, Villejuif, France. [email protected].
¹⁰ FCRIN INI-CRCT, Paris, France. [email protected].
¹¹ INSERM CIC 1433, Nancy CHRU and University of Lorraine, Nancy, France.

No abstract available

Publication types